Elsevier

World Neurosurgery

Volume 133, January 2020, Pages e31-e61
World Neurosurgery

Original Article
Influence of the Matrix Metalloproteinase 9 Geners3918242 Polymorphism on Development of Ischemic Stroke: A Meta-analysis

https://doi.org/10.1016/j.wneu.2019.08.026Get rights and content

Background

The association between matrix metalloproteinase 9 (MMP-9) gene -1562C/T (rs3918242) polymorphism and the susceptibility of ischemic stroke (IS) has been investigated. However, results were ambiguous and inconsistent. Therefore, we performed this study to better assess the potential relationship between rs3918242 polymorphism and susceptibility risk of IS.

Methods

We included case-control studies concerning the relationship between the rs3918242 polymorphism and IS, and odds ratios with corresponding 95% confidence intervals were used to describe the associations. Furthermore, meta-regression analyses, heterogeneity, cumulative analyses, sensitivity analyses, and publication bias were examined.

Results

A total of 19 studies were included for analysis. Significant associations with the risk of IS were detected for the rs3918242 polymorphism in overall population, Asians, and whites. When available data were stratified by gender, we found a significant correlation with the risk of IS in both males and females. Further subgroup analysis by the subtypes of IS showed that the rs3918242 polymorphism was significantly correlated with the risk of patients with large artery atherosclerosis. When stratified by age, we found that the rs3918242 polymorphism was significantly correlated with the risk of IS in patients both aged ≥65 years and >65 years. Both the diabetes and the nondiabetes subgroups reached significant results, and in an analysis stratified by smoking status, an increased risk of IS was associated with smoking.

Conclusions

The rs3918242 polymorphism may be a susceptible predictor of susceptibility of IS. Further large-scale studies are needed to verify the results of our findings.

Introduction

Stroke is the second most common cause of death in the world as well as the leading cause of long-term disability worldwide.1 Approximately 80%–90% of strokes are ischemic stroke (IS).2, 3 However, the cause of IS is not well known. Multiple traditional risk factors such as hypertension, diabetes, dyslipidemia, high body mass index (BMI), poor diet, lack of exercise, smoking, alcohol drinking, hyperhomocysteinemia, are associated with a higher risk of IS.4 However, these factors can explain only a small part of the cause.5 Evidence from twins, families, and animal model studies indicated that gene polymorphisms also exerted influence on IS susceptibility and prognosis.6, 7, 8 Thus, besides traditional risk factors, genetic factors may also contribute to a substantial proportion of the risk and prognosis of IS.9, 10

Much scientific research has indicated that inflammation plays a crucial role in the pathogenesis of stroke.11, 12 Inflammatory mediators can participate in the rapid evolution of arteriosclerosis injury, which leads to arterial plaque rupture and arterial thrombosis.13, 14 Matrix metalloproteinase (MMP) is an inflammatory mediator that belongs to a family of structurally related zinc-binding proteolytic enzymes, which are widely distributed in human tissues. MMPs are produced by nerve cells, microglia, endothelial cells, and astrocytes and play a major role in the physiologic degradation of extracellular matrix during angiogenesis, tissue repair, and tissue morphogenesis.15 MMP-9 is an important member of the MMP family; among all MMPs, MMP-9 is the most widely investigated enzyme in acute IS, and its expression is rapidly upregulated after cerebral ischemia and hypoxia.16, 17 The human MMP-9 gene is located on the long arm of chromosome 20 (20q12.2–13.1), consisting of 13 exons and 12 introns, and some key functional polymorphisms have been reported,18 which may lead to the penetration of leucocytes and destabilization of atherosclerotic plaques.19

The MMP-9 -1562C/T polymorphism (rs3918242) located in the MMP-9 gene promoter has been reported to be associated with higher MMP-9 circulating concentrations.19 Several studies have been conducted in the past to depict the association between MMP-9 gene -1562C/T polymorphism and IS susceptibility.20, 21, 22 However, the existing findings are controversial and indefinite. This discrepancy might result from the demographic, profound ethnic differences, and small sample sizes. To accurately identify the genetic role of this single nucleotide polymorphism in stroke development, we carried out this systematic meta-analysis to clarify the relationship between the MMM-9 gene -1562C/T polymorphism and IS susceptibility.

Section snippets

Literature Search

Original studies evaluating the relationship between the MMP-9 gene-1562 C/T (rs3918242) polymorphism and IS before January 15, 2019 were considered. Six electronic databases including PubMed, EMBASE, and the Chinese Biological Medical Literature database, as well as the Chinese National Knowledge Infrastructure database, Chinese Wanfang database, and Chongqing VIP database were all searched independently by 2 investigators (G.L.W. and H.Y.C.). The literature search results were limited to

Selection Process and Study Characteristics

Figure 1 is a flow diagram of the study identification and selection process. According to the inclusion criteria, 204 studies were identified. After screening the titles and abstracts, most of the articles were excluded because of missing information on the association between the MMP-9 gene -1562C/T (rs3918242) polymorphism and IS. We excluded 1 article,31 because it did not provide sufficient correctly data about allele frequency or genotype frequency. Nineteen studies24, 32, 33, 34, 35, 36,

Discussion

In this study, we investigated the association of an important polymorphism of the MMP-9 gene rs3918242 (-1562C/T) with the risk of IS. Our research results indicated a significant association between the MMP-9 gene -1562C/T polymorphism and the susceptibility risk of IS. The presence of the MMP-9 rs3918242 T allele conferred a higher risk of developing IS, which may have resulted from the interaction with diabetes and smoking. Moreover, significantly increased risks of IS were found in

Conclusions

Our findings support the existence of an association between the MMP-9 rs3918242 polymorphism and the risk of developing IS. In particular, smokers carrying the rs3918242 T allele of MMP9, which is associated with increased MMP9 levels, may run a higher risk of developing IS. Our study may provide clues for the evaluation of individual susceptibility to IS and for the development of effective measures to control and prevent IS.

References (67)

  • A. Maasz et al.

    Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned

    Genome Med

    (2010)
  • L.B. Goldstein et al.

    Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

    Stroke

    (2011)
  • E. Flossmann et al.

    Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke

    Stroke

    (2004)
  • B. Jeffs et al.

    Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus

    Nat Genet

    (1997)
  • W. He et al.

    Methylene tetrahydrofolate reductase (MTHFR) rs868014 polymorphism regulated by miR-1203 associates with risk and short term outcome of ischemic stroke

    Cell Physiol Biochem

    (2017)
  • NINDS Stroke Genetics Network (SiGN); International Stroke Genetics Consortium (ISGC). Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study

    Lancet Neurol

    (2016)
  • A. Lindgren

    Stroke genetics: a review and update

    J Stroke

    (2014)
  • P.J. Lindsberg et al.

    Inflammation and infections as risk factors for ischemic stroke

    Stroke

    (2003)
  • L. Gu et al.

    Association between TNF-delta 238G/A polymorphisms and the risk of ischemic stroke

    Int J Neurosci

    (2013)
  • J.M. Freije et al.

    Matrix metalloproteinases and tumor progression

    Adv Exp Med Biol

    (2003)
  • C. Foerch et al.

    Invited article: searching for oracles? Blood biomarkers in acute stroke

    Neurology

    (2009)
  • C.C. Alcantara et al.

    Different error size during locomotor adaptation affects transfer to overground walking poststroke

    Neurorehabil Neural Repair

    (2018)
  • B. Zhang et al.

    Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1

    Hum Genet

    (1999)
  • S. Blankenberg et al.

    Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

    Circulation

    (2003)
  • B. Wang et al.

    MMP-9 gene rs3918242 polymorphism increases risk of stroke: a meta-analysis

    J Cell Biochem

    (2018)
  • P.K. Whelton et al.

    2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

    Hypertension

    (2018)
  • Y. Li et al.

    Association of polymorphisms of the matrix metalloproteinase 9 gene with ischaemic stroke in a Southern Chinese population

    Cell Physiol Biochem

    (2018)
  • G.A. Wells et al.

    The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses

  • M. Egger et al.

    Bias in meta-analysis detected by a simple, graphical test

    BMJ

    (1997)
  • H.H. Gao et al.

    Genetic polymorphisms in the ESR1 gene and cerebral infarction risk: a meta-analysis

    DNA Cell Biol

    (2014)
  • J.P. Ioannidis et al.

    Reasons or excuses for avoiding meta-analysis in forest plots

    BMJ

    (2008)
  • C.B. Begg et al.

    Operating characteristics of a rank correlation test for publication bias

    Biometrics

    (1994)
  • X. Kong et al.

    Correlation of MMP-9 gene polymorphism with the pathogenesis and prognosis of patients with ischemic stroke

    Prog Modern Biomed

    (2017)
  • Cited by (15)

    • Dataset of allele and genotype frequencies of the three functionally significant polymorphisms of the MMP genes in Russian patients with primary open-angle glaucoma, essential hypertension and peptic ulcer

      2020, Data in Brief
      Citation Excerpt :

      The dataset contains the raw data (supplementary Table), frequencies of alleles and genotypes (Table 1) for three SNPs of two MMP genes (rs1799750 MMP1, rs3918242 and rs17576 MMP9) in Russian patients diagnosed with POAG, EH, and PU. These polymorphisms were previously reported for their association with POAG, EH, and PU (Table 2) [1–45]. The studied SNPs manifest the regulatory potential (Table 3), which is evidenced by several eQTLs (Table 4) and splicing QTLs (Table 5).

    View all citing articles on Scopus

    Conflict of interest statement: This study was supported by grants from the Guangzhou Science and Technology Project (number 201604020003), the Project of TCM Science and Technology in Guangdong Provincial Hospital of Chinese Medicine (number YN2016ZD04), the Southern China Registry Study of Cerebrovascular Disease on Traditional Chinese Medicine, and the Precision Medical Innovation Platform Construction Project of Guangdong Province.

    Guangliang Wu and Haiyan Cai are co-first authors.

    View full text